November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
ESTRO – To Escalate or to De-Escalate Radiation Dose in Stage 3 NSCLC?
Jul 25, 2024, 23:48

ESTRO – To Escalate or to De-Escalate Radiation Dose in Stage 3 NSCLC?

European Society for Radiotherapy and Oncology shared on LinkedIn:

“Key insights from ESTRO24 on the optimisation of radiation doses for stage III NSCLC in the era of immunotherapy and tyrosine kinase inhibitors. Learn about dose escalation trials, individualised treatment strategies, and the role of biomarkers in the guidance of therapy.”

Read further.
Source: European Society for Radiotherapy and Oncology/LinkedIn